Insurances & Business

News Economy Business Investment Banks Credits

Human Genome Sciences shares fall on drug candidate swap (AP)

Shares of Human Genome Sciences fell Thursday after the biotechnology company bought back the rights to its cancer treatments, a move one analyst said eliminates the possibility of a buyout.

Leave a Reply »»

Similar/Related/News: